Howard Fingert, M.D.

Vice President, Clinical Research Oncology, Alkermes, Inc.

Dr. Fingert is vice president of clinical research oncology at Alkermes, Inc. in Waltham, Massachusetts. He worked in the biotech/pharma industry for more than 25 years after serving in academic faculty positions at Harvard and Tufts medical schools. He has published experience in phases 1-4 clinical trials, cancer biomarkers, pharmacology, safety risk management and regulatory sciences. In addition to cross-functional experience, conducting multi-regional trials and successful product registrations, he has been engaged in public-private partnerships with patient advocacy organizations, academic centers, the Biden Moonshot initiatives and the National Cancer Institute, and he recently served as industry representative to the Oncology Drugs Advisory Committee of the U.S. Food and Drug Administration.